Chandra Bhagat — 360° view

Chandra Bhagat, a company in the Pharmaceuticals industry, reported revenue of ₹80 crore and net profit of ₹3.00 crore for the September 2026 quarter.

Chandra Bhagat (BSE: CBPL) closed at ₹67.00 on 20 Nov 2026, up 67.7% over the past year. Its market capitalisation is ₹51 crore and it trades at 9.7 times earnings.

Share price
₹67.00 (20 Nov 2026)
Market cap
₹51 Cr (20 Nov 2026)
P/E
9.65 (20 Nov 2026)
Revenue
₹80 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
12.1% (FY26)
ROE
9.67% (FY26)
Book value
₹47.4 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹72.92 / ₹29.70 (20 Nov 2026)
1-year return
67.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: CBPL

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.